300 related articles for article (PubMed ID: 28534996)
1. Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.
Zhang E; Shi H; Yang L; Wu X; Wang Z
Oncol Rep; 2017 Jul; 38(1):359-367. PubMed ID: 28534996
[TBL] [Abstract][Full Text] [Related]
2. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.
Pang X; Yi Z; Zhang J; Lu B; Sung B; Qu W; Aggarwal BB; Liu M
Cancer Res; 2010 Mar; 70(5):1951-9. PubMed ID: 20160026
[TBL] [Abstract][Full Text] [Related]
3. Quercetin inhibits angiogenesis mediated human prostate tumor growth by targeting VEGFR- 2 regulated AKT/mTOR/P70S6K signaling pathways.
Pratheeshkumar P; Budhraja A; Son YO; Wang X; Zhang Z; Ding S; Wang L; Hitron A; Lee JC; Xu M; Chen G; Luo J; Shi X
PLoS One; 2012; 7(10):e47516. PubMed ID: 23094058
[TBL] [Abstract][Full Text] [Related]
4. SB365 inhibits angiogenesis and induces apoptosis of hepatocellular carcinoma through modulation of PI3K/Akt/mTOR signaling pathway.
Hong SW; Jung KH; Lee HS; Choi MJ; Son MK; Zheng HM; Hong SS
Cancer Sci; 2012 Nov; 103(11):1929-37. PubMed ID: 22909393
[TBL] [Abstract][Full Text] [Related]
5. Secalonic Acid-D Represses HIF1α/VEGF-Mediated Angiogenesis by Regulating the Akt/mTOR/p70S6K Signaling Cascade.
Guru SK; Pathania AS; Kumar S; Ramesh D; Kumar M; Rana S; Kumar A; Malik F; Sharma PR; Chandan BK; Jaglan S; Sharma JP; Shah BA; Tasduq SA; Lattoo SK; Faruk A; Saxena AK; Vishwakarma RA; Bhushan S
Cancer Res; 2015 Jul; 75(14):2886-96. PubMed ID: 25977334
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
7. 5,3'-Dihydroxy-6,7,4'-trimethoxyflavanone exerts its anticancer and antiangiogenesis effects through regulation of the Akt/mTOR signaling pathway in human lung cancer cells.
Kim KM; Heo DR; Lee J; Park JS; Baek MG; Yi JM; Kim H; Bang OS
Chem Biol Interact; 2015 Jan; 225():32-9. PubMed ID: 25446852
[TBL] [Abstract][Full Text] [Related]
8. Luteolin inhibits human prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
Pratheeshkumar P; Son YO; Budhraja A; Wang X; Ding S; Wang L; Hitron A; Lee JC; Kim D; Divya SP; Chen G; Zhang Z; Luo J; Shi X
PLoS One; 2012; 7(12):e52279. PubMed ID: 23300633
[TBL] [Abstract][Full Text] [Related]
9. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
[TBL] [Abstract][Full Text] [Related]
10. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
11. Delphinidin inhibits angiogenesis through the suppression of HIF-1α and VEGF expression in A549 lung cancer cells.
Kim MH; Jeong YJ; Cho HJ; Hoe HS; Park KK; Park YY; Choi YH; Kim CH; Chang HW; Park YJ; Chung IK; Chang YC
Oncol Rep; 2017 Feb; 37(2):777-784. PubMed ID: 27959445
[TBL] [Abstract][Full Text] [Related]
12. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
13. SKLB-M8 induces apoptosis through the AKT/mTOR signaling pathway in melanoma models and inhibits angiogenesis with decrease of ERK1/2 phosphorylation.
Wang J; Yang Z; Wen J; Ma F; Wang F; Yu K; Tang M; Wu W; Dong Y; Cheng X; Nie C; Chen L
J Pharmacol Sci; 2014; 126(3):198-207. PubMed ID: 25341684
[TBL] [Abstract][Full Text] [Related]
14. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
15. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer.
Zhou X; Yue GG; Chan AM; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Biochem Pharmacol; 2017 Oct; 142():58-70. PubMed ID: 28669564
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway.
Li G; Shan C; Liu L; Zhou T; Zhou J; Hu X; Chen Y; Cui H; Gao N
PLoS One; 2015; 10(2):e0117440. PubMed ID: 25659153
[TBL] [Abstract][Full Text] [Related]
17. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells.
Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC
Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035
[TBL] [Abstract][Full Text] [Related]
18. Ampelopsin suppresses breast carcinogenesis by inhibiting the mTOR signalling pathway.
Chang H; Peng X; Bai Q; Zhou Y; Yu X; Zhang Q; Zhu J; Mi M
Carcinogenesis; 2014 Aug; 35(8):1847-54. PubMed ID: 24861637
[TBL] [Abstract][Full Text] [Related]
19. Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2.
Rho SB; Song YJ; Lim MC; Lee SH; Kim BR; Park SY
Cell Signal; 2012 Jan; 24(1):131-9. PubMed ID: 21893193
[TBL] [Abstract][Full Text] [Related]
20. ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous metastasis of human breast cancer cells.
Klos KS; Wyszomierski SL; Sun M; Tan M; Zhou X; Li P; Yang W; Yin G; Hittelman WN; Yu D
Cancer Res; 2006 Feb; 66(4):2028-37. PubMed ID: 16489002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
